Please assess the completion status of the following clinical trial:

Trial Title: Stem Cell Collection for Adult Volunteers

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
* INCLUSION CRITERIA:~Age 18 or greater.~Normal renal function: creatinine less than1.5 mg/dL, proteinuria less than1+.~Normal liver function: bilirubin less than 2.5 mg/dL, ALT less than 2.5 times the upper limit of normal, all other transminases less than 2.5 times the upper limit of normal.~Normal blood counts: WBC 3,000-10,000/mm3, granulocytes greater than 1,500/mm3, platelets greater than 150,000/mm3, hemoglobin greater than 12.5g/dL, MCV within normal limits.~Female volunteers of childbearing age should have a negative serum pregnancy test within one week of beginning G-CSF administration.~Meets NIH Department of Transfusion Medicine (DTM) eligibility criteria for blood component donation for in vitro research use (negative serologic tests for syphilis, hepatitis B and C, HIV, and HTLV-1).~Ability to give informed consent to participate in the protocol.~EXCLUSION CRITERIA:~Any underlying hematologic disorder including sickle cell disease.~Active viral, bacterial, fungal, or parasitic infection.~History of autoimmune disease, such as rheumatoid arthritis or systemic lupus erythematosus.~History of cancer excluding squamous carcinoma of the skin and cervical carcinoma in situ.~History of cardiovascular disease or related symptoms such as chest pain or shortness of breath.~Any positive serum screening test as listed below.~Allergy to G-CSF or bacterial E. coli products.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: None): Eligible healthy volunteers 18 and older

Based on this trial design, predict the completion outcome and termination type (if applicable).